Abstract
Background
Young adults (YAs, ages 18–39) diagnosed with cancer face multiple challenges that affect their health-related quality of life, including the potential for cancer-related infertility. Providing information about the risk of infertility and options to maintain fertility is critical for YAs who are newly diagnosed. However, barriers to effective communication exist for oncologists and their patients. The purpose of this study was to interview medical oncologists and YAs from the same cancer center to examine attitudes and practices about fertility preservation.
Methods
Semi-structured interviews were conducted with medical oncologists (N=12) and YAs within 2 years post-treatment (N=24), representing the most common cancers affecting YAs. Interviews were audio-recorded, transcribed, and coded using qualitative methodologies with the analysis software NVivo 10.
Results
Twelve oncologists (50% female, 67% <50 years) and 24 YAs (67% female, M=29 years) completed interviews. Common themes across oncologist and YA interviews were the roles of cancer type or stage and patient interest or parity in influencing the decision. The most important factor for YAs was to receive accurate, in-depth information. Unique themes for oncologists focused on clinical aspects of their patient’s disease. For YAs, they shared about the emotional impact of cancer-related infertility and desire for support from trusted others.
Conclusions
Results provide a better understanding of the attitudes and practices about fertility preservation discussions among YAs. Given the common factors affecting fertility preservation decisions, models of shared decision-making may be ideal for YAs and oncologists. Future interventions should explore tailored applications of this approach for YAs newly diagnosed with cancer.
Similar content being viewed by others
Explore related subjects
Discover the latest articles, news and stories from top researchers in related subjects.Avoid common mistakes on your manuscript.
Introduction
Approximately 90,000 young adults (YAs, ages 18–39) in the USA are diagnosed with cancer annually [1]. This can significantly affect their health-related quality of life, including infertility or other reproductive challenges [1]. Numerous national organizations [2,3,4] have established guidelines to enhance oncologist adherence and facilitate patient and oncologist discussions about fertility preservation options prior to proceeding with fertility compromising treatments. With few exceptions [5,6,7], adherence to guidelines to discuss fertility preservation options with patients is suboptimal [8,9,10,11,12].
Lack of communication about fertility preservation options with YAs may be due to several factors. Oncologists face many communication challenges when discussing fertility preservation with their patients. These challenges can be related to oncologist attributes (e.g., knowledge barriers), patient attributes (e.g., cultural or religious prohibitions for assisted reproduction), and healthcare or institutional factors (e.g., time demands) [13,14,15,16,17]. Institutional resources to support fertility preservation decision-making are highly variable [18, 19].
YAs want to be fully informed about their infertility risks and options for having children. Yet this information remains a common unmet need [20,21,22,23]. It is critical for institutions to ensure that fertility preservation communication occurs as soon as possible after diagnosis so that patients are appropriately informed and able to make decisions based on values, priorities, and goals that may or may not include fertility preservation procedures. Thus, the goal of this study is to explore attitudes and practices about fertility preservation using qualitative, semi-structured individual interviews with medical oncologists and YAs from the same cancer center. By examining these patterns, we are well-positioned to identify where oncologists’ and YAs’ perspectives converge and diverge and strengthen the evidence base to inform future care.
Methods
Participants and procedures
This work was conducted in compliance with the Northwestern University Institutional Review Board. Oncologists were eligible if they were attending medical oncologists at the Robert H. Lurie Comprehensive Cancer Center (RHLCCC) and treated patients with common cancer types in YAs: breast, gynecologic, neurologic, gastrointestinal, sarcoma, lymphoma, leukemia, and genitourinary/urologic. Medical oncologists at RHLCCC complete a best practice alert in the YA’s medical record to confirm their discussions about potential treatment-related infertility and to provide referrals for more in-depth discussions with reproductive specialists, if needed. RHLCCC has a full-time fertility patient navigator and numerous institutional resources to address patients’ reproductive health concerns, representing a “best case” scenario for addressing YAs’ reproductive health needs. For this purposive sample, the study principal investigator (JS) contacted 12 eligible oncologists to describe the study and all consented to be interviewed.
YAs were eligible if they were diagnosed with one of the above cancer types between the ages of 18 and 39, treated at RHLCCC, within 2 years post-treatment, and met with a fertility navigator or reproductive specialist (regardless of a decision to engage in assisted reproduction). We reviewed YA data from the electronic medical record to pre-screen for eligibility. After obtaining oncologists’ permission to contact their patients, 49 YAs were called by the study coordinator, and 37 YAs were screened. Of those, 1 YA declined, but 36 YAs were eligible and agreed to participate with 24 YAs (67%) returning signed consents.
Semi-structured interviews
All interviews, oncologist and YAs, were audio-recorded, transcribed, and de-identified in preparation for qualitative analysis. Oncologist and YA interview guides are available in the Appendix. All interviewers (JS, BY, AA, and MS) had prior experience conducting semi-structured interviews and received additional training from a qualitative researcher and study co-investigator (DV, a counseling psychologist) prior to data collection.
Oncologist interviews were conducted in person in their private offices. Interviewees and interviewers were matched by sex. Both interviewers (JS and BY) were Ph.D. behavioral scientists and trained in clinical psychology. Oncologist interviews lasted 8 to 32 min (M=17 min). Interviews with YAs were completed by phone and conducted by study investigator (JS) and study team members (AA and MS) who were both master’s level trained in public health. YA interviews lasted 16 to 39 min (M=23 min), and YAs received a $35 VISA gift card.
Statistical analysis
Data were analyzed by two coders for thematic content related to fertility preservation using NVivo10.0. An inductive coding style was used, whereby themes were identified in an iterative fashion. Our first step was to discuss the general sense of the participants’ experiences (oncologists and YAs) based on an initial review of the transcripts. Our second step was to begin coding the data. We established coding rules and definitions, which led to the development of our initial codebook. Two reviewers (JS and BY for the oncologist data; JS and MS for the YA data) independently read and exhaustively coded text passages of the same transcripts. The degree of interrater reliability between coders ranged from 80 to 98%. Our third step was to evaluate data saturation, or the extent to which no new codes emerged. Data saturation was present by the 9th oncologist interview and by the 6th YA interview, suggesting that all relevant information was sufficiently captured within the number of interviews conducted.
Results
Sample descriptions
Twelve medical oncologists participated in the interviews (67% >50 years of age; 50% female). Twenty-four YAs (M=29 years of age) participated in the interviews. These YAs were primarily female (62.5%) and non-Hispanic white (58.3%) and had a range of cancer diagnoses: leukemia (17%), lymphoma (17%), brain (13%), breast (13%), sarcoma (13%), colorectal (8%), endometrial (8%), testicular (8%), and uterine (4%). All YAs met with a fertility patient navigator and were medically able to undergo fertility preservation if desired. Sixty-seven percent engaged in fertility preservation (9 banked eggs/embryos, 5 banked sperm, and 2 used gonadotropin releasing hormone agonist therapy) and 33% (5 women and 3 men) decided against assisted reproduction. All YAs were post-treatment survivors at the time of the interview.
Semi-structured interviews (N=12 oncologists and N=24 YAs)
Seventeen themes were identified across both samples. Nearly half of the themes (8/17=47%) were discussed by both groups, five themes (5/17=29%) were unique to YAs, and four themes (4/17=24%) were unique to oncologists. The most frequently used themes for oncologists were “age,” “patient interest or parity,” “cancer type/stage,” and “treatment.” In contrast, “treatment” and “patient interest or parity” were also commonly used themes for YAs, but “knowledge,” “emotional impact,” and “trusted others’ perspectives” were relatively more important (Fig. 1). Table 1 provides a complete summary of the number of YAs who endorsed each theme and the frequency with which each theme was endorsed. With the exception of the “comfort” theme, male and female YAs had similar frequency patterns across all themes (≤4% difference in # of references). Example quotes for all themes are provided in Table 2. Full data are available upon request.
Shared themes from oncologists and YAs
Knowledge/information
The most commonly reported theme for YAs was knowledge. It was the only theme described by all YAs and included a range of disclosures about reproductive health, cancer-related infertility, or fertility preservation options. Some YAs did not recall receiving information to guide their decision-making, while others felt sufficiently informed. Notably, the need for or receipt of clear information was a theme discussed at a much higher rate among YAs than oncologists. Only one oncologist spoke about knowledge as a barrier or facilitator of decision-making, and when it was discussed, it was to describe the lack of patient knowledge.
Cancer type/stage
The most commonly reported theme for oncologists was a patient’s cancer type or stage of diagnosis. The type and stage of cancer may impact the timing of treatment initiation and the potential to accommodate fertility preservation procedures. This can be particularly true among some of the more common cancer types in YAs such as hematologic malignancies and breast cancer. While YAs also mentioned these clinical factors, oncologists discussed them at a much higher rate.
Age
In addition to oncologists’ focus on patients’ cancer type or stage of diagnosis, all oncologists prioritized age as a key factor in their conversations about fertility. For male patients, oncologists would consider a much wider age range, whereas for female patients, oncologists typically prioritized those discussions for women until their mid-40s. Age was rarely mentioned by patients, and when it was, it was typically to reflect on information their oncologist had shared with them.
Parity/interest
YAs and oncologists frequently talked about the number of children patients had and if there was a desire for more biological children. Some YAs expressed concern that their cancer diagnosis and potential infertility would make them less desirable partners, and so their interest in preserving their fertility was a priority to mitigate those fears. Others had actively been thinking about and planning to have children. Oncologists were intentional about discussing patients’ interest in future biological children and discussed this theme at a relatively higher frequency than YAs.
Treatment
Discussions about the potential gonadotoxic effects of treatment were important, relatively common, and equally salient for YAs and oncologists. YAs expressed awareness of how the treatment would impact their reproductive potential. Oncologists also described ambiguity in situations when a definitive determination of impact on fertility could not be made.
The remaining shared themes comprised <10% of the content for YAs or oncologists:
Financial/insurance
Most YAs mentioned the various costs associated with assisted reproduction and the role it had in contributing to their decision. In this sample, YAs who proceeded with assisted reproduction and those who did not discussed this factor at the same, relatively low rate (5%). All oncologists described the role of finances or insurance but did not prioritize those discussions with patients (allowing the social worker to address those concerns). They acknowledged the need to “be sensitive” to that component of the decision-making process.
Comfort
YAs described how emotionally comfortable (or not) they felt when discussing fertility options with their oncologists. Though rarely mentioned by oncologists, they would describe how the conversation might be awkward or uncomfortable for younger patients with their parents in the room.
Cultural/religious beliefs
Both oncologists and YAs discussed the role that their cultural or religious values or beliefs had in influencing their fertility preservation decision-making. This was the least mentioned shared theme and discussed by the fewest number of YAs. When cultural or religious beliefs were disclosed, they were typically shared as a reason for not pursuing assisted reproduction.
Unique themes from patients
Emotional impact
The emotional challenge of navigating potential cancer-related infertility and uncertainty was the most frequently reported unique theme among YAs. They reported anxiety/worry/fear, depression/sadness, and even regret.
Trusted others’ perspectives
For many YAs, deciding if and how to move forward with fertility preservation was a process that involved multiple conversations, typically with a partner but also included professionals, family members, and close friends. This reflected a continuation of prior conversations about family building and also reflected more complicated conversations about surrogacy.
Positive reappraisal
The emotional impact of navigating a decision about fertility preservation was often negative. It was not exclusively so, however, as some YAs spoke of reframing their experience in more positive terms. This was typically an adaptive coping strategy used to re-affirm the fertility preservation decision that was made.
E-support
Still other YAs described their use of and reliance on Google, YouTube, websites, blogs, or a variety of e-tools. These resources were typically used to address knowledge gaps or seek confirmation for decisions made. Still others used these tools as a means of support to learn from others who had navigated similar situations.
Fertility preservation side effects
Perhaps surprisingly, potential side effects from the fertility preservation options were infrequently discussed by YAs. When they were disclosed, it was typically focused on the invasive nature of certain procedures and was only shared by the female participants. Oncologists likely did not reference this theme because these discussions were often the purview of the reproductive endocrinologist.
Unique themes from oncologists
Patient readiness for preservation
Oncologists would occasionally reference the stage that a patient was in with respect to fertility preservation. They might describe them as being unaware and not having considered it at all vs. thinking through the options and undecided vs. knowing that they want to move forward with specific fertility preservation options. These conversations would obviously impact potential referrals to reproductive specialists.
Physicians’ values
Some oncologists would acknowledge the degree to which their beliefs and attitudes influence discussions about fertility preservation. This often emerged for oncologists when treating a patient that had a poor prognosis or limited resources. They might voice an internal tension between the ability to do something (i.e., assisted reproduction) and whether that option is the “best” decision given the patient’s circumstances.
Sex
For oncologists that treated patients of both sexes, they would discuss the role that biologic sex plays in fertility preservation decision-making. This would often overlap with the treatment plan and cancer type/stage discussions since the importance of timing and ease of a fertility preservation procedure (e.g., sperm banking) vs. more invasive approaches (e.g., egg freezing) were typically emphasized.
Time
One of the least frequently discussed themes was the amount of time oncologists spent discussing fertility preservation concerns with patients. For those that referenced it, they described how that aspect of the treatment planning visit would be prioritized relative to other considerations and how it aligned (or not) with the patients’ needs and priorities.
Discussion
This qualitative study of stakeholder attitudes and practices about fertility preservation decision-making reveals key considerations for factors that may represent an important disconnect between YAs and their oncologists as well as those that are relatively unique to YAs and those that are more salient to oncologists. Collectively, these themes validate and strengthen the substantive literature on fertility preservation decision-making among YAs, the priorities for oncologists, and opportunities for improvement. Moreover, they also point to the potential value of a multilevel approach to better address this important, patient-centered priority among YAs.
First, among the shared themes, the largest discrepancy between YA and oncologist perspectives was the role of knowledge in the decision-making process. YAs highlighted both the benefits of adequate and in-depth knowledge in order to foster informed decision-making. Regrettably, some YAs also expressed frustration over the lack of information about the extent to which cancer and treatment would affect their fertility. This was understandably linked to expressions of decisional regret, distress, and grief—common reactions among YAs who have experienced reproductive concerns post-treatment [24, 25]. Oncologists described the role of knowledge of risks and options infrequently. What is often said in the visit is not always what is remembered or understood by YAs, and it is critical to check for comprehension [26, 27]. Accordingly, models of shared decision-making may be well received by patients and oncologists [23]. This places the onus on YAs to be informed “consumers” of information and to advocate for themselves as well as on the oncologist to allow time and “space” for these conversations to occur.
Additional YA priorities include managing their affective response to the situation and the role of significant others in their lives who provide support. For YAs, the experience is often significantly distressing and represents a non-normative event [28, 29]. Moreover, the potential for cancer to impair fertility sometimes “adds insult to injury,” and so there is a clear need for YAs to not only receive informational support but emotional support as well. This can be in the form of psychosocial support or even skilled fertility patient navigators, who can address these affective needs or provide referrals for patients who are in greater distress [30]. Involving trusted others in the decision-making can provide support and clarify YAs’ priorities and goals [31].
For oncologists, the most salient themes were clinical factors associated with type of cancer, stage of disease, and patient sex. This is not unusual given the need for oncologists to make evidence-based recommendations [2,3,4]. An ongoing challenge, however, is that models of gonadotoxic risk are constantly in need of updating. With newer targeted therapies, the potential risk is unknown, and the impact on fertility may take years to be identified [32]. In addition, YAs may misunderstand quantitative risk estimates. As such, communication experts advocate messaging that conveys the potential risk for any treatment to impact fertility, and if preserving fertility is a priority to a patient, s/he should have a conversation with a reproductive specialist [33].
This study has a few limitations. All YAs and oncologists were from a comprehensive cancer center that has multiple resources to support oncologists and patients who have reproductive health concerns, so these findings may not be representative of the larger YA community. That said, the communication disconnects and priorities identified here are not a priori inconsistent with what we might find if the study were replicated in community settings. Moreover, the discrepancy for knowledge may even be greater, pointing to the need for scalable and multilevel interventions to support information needs of patients. Secondly, the interviews represent retrospective accounts of YAs’ experiences with their decision-making about fertility. Although we intentionally included YAs who were within 2 years post-treatment, the salience of some events may have passed, and the degree to which YAs may be more settled in their decisions may obscure the real-time factors that impacted their decisions. Thirdly, we cannot rule out some self-selection bias in our YA sample. We intentionally recruited YAs who considered fertility preservation but decided against it in order to capture a range of experiences, but it is possible that YAs who may have had more negative experiences were not likely to participate. Lastly, we did not specifically focus on dyadic, oncologist, and YA relationships. Examining the attitudes and practices about fertility preservation within dyads would prove even more illuminating and would be an important future direction.
In summary, these findings point to the critical role that knowledge serves in fertility preservation decision-making and the complementary ways that YAs and oncologists can leverage their respective affective and cognitive experiences to foster shared decision-making. It is important to identify factors that can support and empower patients to advocate for themselves. To address knowledge deficits among YAs and support those who may have limited access to reproductive specialists, future work should focus on the development and testing of fertility preservation decision aids to examine feasibility, acceptability, and efficacy [34,35,36]. Further, multilevel interventions that address the individual patient needs as well as contextual influences (e.g., providers, organizations) [37] may be particularly well suited to support fertility-preservation decision-making. YAs would benefit from more information about how the treatment will impact fertility, how preservation works, how preservation can influence their disease progression and prognosis, and the need for contraception [32, 38,39,40]. Oncologists can benefit from additional guidance on how to introduce the topic and knowledge of referral resources [41,42,43,44,45]. This can be strengthened through awareness of YA’s interest in preservation and knowing when to initiate a discussion about preservation. Ultimately, the design and testing of tools to support shared decision-making about fertility preservation is a growing area and may enhance patient-centered care for YAs with cancer.
Data Availability
All data are available upon request.
Code availability
Not applicable.
References
American Cancer Society (2020) Cancer facts & figures 2020. American Cancer Society, Atlanta
(2018) Fertility preservation and reproduction in patients facing gonadotoxic therapies: an ethics committee opinion. Fertil Steril 110:380–386
Oktay K, Harvey BE, Partridge AH, Quinn GP, Reinecke J, Taylor HS, Wallace WH, Wang ET, Loren AW (2018) Fertility preservation in patients with cancer: ASCO clinical practice guideline update. J Clin Oncol 36:1994–2001
Coccia PF, Pappo AS, Beaupin L, Borges VF, Borinstein SC, Chugh R, Dinner S, Folbrecht J, Frazier AL, Goldsby R, Gubin A, Hayashi R, Huang MS, Link MP, Livingston JA, Matloub Y, Millard F, Oeffinger KC, Puccetti D, Reed D, Robinson S, Rosenberg AR, Sanft T, Spraker-Perlman HL, von Mehren M, Wechsler DS, Whelan KF, Yeager N, Gurski LA, Shead DA (2018) Adolescent and young adult oncology, Version 2.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Cancer Netw 16:66–97
Bowman-Curci M, Quinn GP, Reinecke J, Reich RR, Vadaparampil ST (2019) Comparing fertility preservation resources and policies between NCCN member and non-member institutions. Support Care Cancer 27:2125–2129
Salsman JM, Yanez B, Smith KN, Beaumont JL, Snyder MA, Barnes K, Clayman ML (2016) Documentation of fertility preservation discussions for young adults with cancer: examining compliance with treatment guidelines. J Natl Compr Cancer Netw 14:301–309
Rosenberg SM, Gelber S, Gelber RD, Krop E, Korde LA, Pagani O, Partridge AH (2017) Oncology physicians' perspectives on practices and barriers to fertility preservation and the feasibility of a prospective study of pregnancy after breast cancer. J Adolesc Young Adult Oncol 6:429–434
Covelli A, Facey M, Kennedy E, Brezden-Masley C, Gupta AA, Greenblatt E, Baxter NN (2019) Clinicians’ perspectives on barriers to discussing infertility and fertility preservation with young women with cancer. JAMA Netw Open 2:e1914511
Quinn GP, Block RG, Clayman ML, Kelvin J, Arvey SR, Lee JH, Reinecke J, Sehovic I, Jacobsen PB, Reed D, Gonzalez L, Vadaparampil ST, Laronga C, Lee MC, Pow-Sang J, Eggly S, Franklin A, Shah B, Fulp WJ, Hayes-Lattin B (2015) If you did not document it, it did not happen: rates of documentation of discussion of infertility risk in adolescent and young adult oncology patients’ medical records. J Oncol Pract 11:137–144
Armuand GM, Rodriguez-Wallberg KA, Wettergren L, Ahlgren J, Enblad G, Höglund M, Lampic C (2012) Sex differences in fertility-related information received by young adult cancer survivors. J Clin Oncol 30:2147–2153
Köhler T, Kondapalli L, Shah A (2011) Results from the survey for preservation of adolescent reproduction (SPARE) study: gender disparity in delivery of fertility preservation message to adolescents with cancer. J Assist Reprod Genet 28:269–277
Letourneau JM, Smith JF, Ebbel EE, Craig A, Katz PP, Cedars MI, Rosen MP (2012) Racial, socioeconomic, and demographic disparities in access to fertility preservation in young women diagnosed with cancer. Cancer. 118:4579–4588
Panagiotopoulou N, Ghuman N, Sandher R, Herbert M, Stewart JA. (2018) Barriers and facilitators towards fertility preservation care for cancer patients: a meta-synthesis. European Journal of Cancer Care 27.
Hudson JN, Stanley NB, Nahata L, Bowman-Curci M, Quinn GP (2017) New promising strategies in oncofertility. Expert Rev Qual Life Cancer Care 2:67–78
Murphy D, Klosky JL, Reed DR, Termuhlen AM, Shannon SV, Quinn GP (2015) The importance of assessing priorities of reproductive health concerns among adolescent and young adult patients with cancer. Cancer. 121:2529–2536
Daly C, Micic S, Facey M, Speller B, Yee S, Kennedy ED, Corter AL, Baxter NN (2019) A review of factors affecting patient fertility preservation discussions & decision-making from the perspectives of patients and providers. Eur J Cancer Care 28:e12945
Johnson RH, Kroon L (2013) Optimizing fertility preservation practices for adolescent and young adult cancer patients. J Natl Compr Cancer Netw 11:71–77
Besharati M, Woodruff T, Victorson D (2016) Young Adults’ access to fertility preservation services at National Cancer Institute Community Oncology Research Program Minority/Underserved Community Sites: a qualitative study. J Adolesc Young Adult Oncol 5:187–200
Rolland B, Eschler J (2018) Searching for survivor-specific services at NCI-designated comprehensive cancer centers: a qualitative assessment. J Natl Compr Cancer Netw 16:839–844
Zebrack BJ, Block R, Hayes-Lattin B, Embry L, Aguilar C, Meeske KA, Li Y, Butler M, Cole S (2013) Psychosocial service use and unmet need among recently diagnosed adolescent and young adult cancer patients. Cancer. 119:201–214
Logan S, Perz J, Ussher JM, Peate M, Anazodo A (2018) A systematic review of patient oncofertility support needs in reproductive cancer patients aged 14 to 45 years of age. Psycho-Oncology. 27:401–409
Barlevy D, Wangmo T, Elger BS, Ravitsky V (2016) Attitudes, beliefs, and trends regarding adolescent oncofertility discussions: a systematic literature review. J Adolesc Young Adult Oncol 5:119–134
Clayman ML, Galvin KM, Arntson P (2007) Shared decision making: fertility and pediatric cancers. Cancer Treat Res 138:149–160
Gorman JR, Su HI, Roberts SC, Dominick SA, Malcarne VL (2015) Experiencing reproductive concerns as a female cancer survivor is associated with depression. Cancer. 121:935–942
Benedict C, Thom B, Kelvin JF (2015) Young adult female cancer survivors' decision regret about fertility preservation. J Adolesc Young Adult Oncol 4:213–218
Tschudin S, Bitzer J (2009) Psychological aspects of fertility preservation in men and women affected by cancer and other life-threatening diseases. Hum Reprod Update 15:587–597
Crawshaw MA, Sloper P (2010) ‘Swimming against the tide’--the influence of fertility matters on the transition to adulthood or survivorship following adolescent cancer. Eur J Cancer Care 19:610–620
Logan S, Perz J, Ussher JM, Peate M, Anazodo A (2019) Systematic review of fertility-related psychological distress in cancer patients: Informing on an improved model of care. Psycho-Oncology. 28:22–30
Ussher JM, Perz J (2019) Infertility-related distress following cancer for women and men: a mixed method study. Psycho-Oncology. 28:607–614
Logan S, Anazodo A (2019) The psychological importance of fertility preservation counseling and support for cancer patients. Acta Obstet Gynecol Scand 98:583–597
Nahata L, Morgan TL, Lipak KG et al (2019) Perceptions of participating in family-centered fertility research among adolescent and young adult males newly diagnosed with cancer: a qualitative study. Pediatr Blood Cancer 66:e27966
Irene Su H, Lee YT, Barr R (2018) Oncofertility: meeting the fertility goals of adolescents and young adults with cancer. Cancer J 24:328–335
Moffitt Cancer Center. Enriching communication skills for health professionals in oncofertility (ECHO). Available from URL: https://echo.rhoinstitute.org/. Accessed 28 April 2020
The Oncofertility Consortium. Oncofertility Decision Tool Web Portal. Available from URL: http://oncofertility.northwestern.edu/resources/oncofertility-decision-tool-web-portal. Accessed 28 April 2020
Wang Y, Anazodo A, Logan S (2019) Systematic review of fertility preservation patient decision aids for cancer patients. Psycho-Oncology. 28:459–467
Benedict C, Thom B, Kelvin JF (2016) Fertility preservation and cancer: challenges for adolescent and young adult patients. Curr Opin Support Palliat Care 10:87–94
Taplin SH, Anhang Price R, Edwards HM, Foster MK, Breslau ES, Chollette V, Prabhu Das I, Clauser SB, Fennell ML, Zapka J (2012) Introduction: understanding and influencing multilevel factors across the cancer care continuum. J Natl Cancer Inst Monogr 2012:2–10
The Oncofertility Consortium. Patient pocket guides. Available from URL: http://www.savemyfertility.org/pocket-guides/patients. Accessed 28 April 2020
Alliance for Fertility Preservation. Fertility scout. Available from URL: https://www.allianceforfertilitypreservation.org/get-involved/fertility-scout. Accessed 28 April 2020
American Society for Reproductive Medicine. ReproductiveFacts.org. Available from URL: https://www.reproductivefacts.org/. Accessed 28 April 2020
Lampic C, Wettergren L (2019) Oncologists' and pediatric oncologists’ perspectives and challenges for fertility preservation. Acta Obstet Gynecol Scand 98:598–603
Kelvin JF (2017) Fertility Preservation in Young Adult Patients With Cancer. Oncology (Williston Park) 31:530, 534-536, 538, 570
Vadaparampil ST, Kelvin J, Murphy D, Bowman M, Sehovic I, Quinn G. (2016) Fertility and fertility preservation: scripts to support oncology nurses in discussions with adolescent and young adult patients. J Clin Outcomes Manag 23.
Perez GK, Salsman JM, Fladeboe K, Kirchhoff AC, Park ER, Rosenberg AR (2020) Taboo topics in adolescent and young adult oncology: strategies for managing challenging but important conversations central to adolescent and young adult cancer survivorship. Am Soc Clin Oncol Educ Book 40:1–15
The Oncofertility Consortium. Provider Pocket Guides. Available from URL: http://www.savemyfertility.org/pocket-guides/providers. Accessed 28 April 2020
Acknowledgements
The authors would like to thank the young adult survivors and oncologists who generously devoted their time to share with us how they navigate conversations about cancer-related infertility and subsequent decisions about fertility preservation.
Funding
Research reported in this publication was supported by the American Cancer Society-Institutional Research Grant under award number ACS-IRG 93-037-18 and the National Cancer Institute of the National Institutes of Health (NIH) under awards number K07 CA158008 & R01 CA218398 (PIs: Salsman).
Author information
Authors and Affiliations
Contributions
John Salsman: Study conception and design, acquisition of data, analysis and interpretation of data, drafting of manuscript, critical revision, and funding acquisitionBetina Yanez: Study conception and design, acquisition of data, analysis and interpretation of data, and critical revisionMallory Snyder: Project administration, acquisition of data, analysis and interpretation of data, and critical revisionAlexis Avila: Acquisition of data and critical revisionMarla Clayman: Critical revisionKristin Smith: Critical revisionKhouri Purnell: Critical revisionDavid Victorson: Study conception and design and critical revision
Corresponding author
Ethics declarations
Ethics approval
This work was conducted in compliance with the Northwestern University Institutional Review Board.
Consent to participate
All participants, oncologists and young adults, provided informed consent to participate in this study.
Consent for publication
No separate consent for publication was obtained. The informed consent document addressed the potential for publication of de-identified data and additional efforts to maintain participant confidentiality.
Conflict of interest
The authors declare no competing interests.
Disclaimer
The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH.
Additional information
Publisher’s note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Appendix. Oncologist and young adult interview guides
Appendix. Oncologist and young adult interview guides
Oncologist Interview Guide
Thank you for taking the time to speak with me today about fertility preservation for young adults with cancer. The purpose of this project is to examine patient and provider perspectives about fertility preservation options among young adults with cancer and their medical oncologists. We are interested in learning more about your experiences concerning fertility preservation for your young adult patients aged 18-39 .
-
1.
Please tell me how you decide when to discuss any fertility-related concerns with your patients.
-
2.
Do you discuss fertility-related concerns with all of your patients? If unclear, probe: Why/why not?
-
3.
On average, how much time do you spend discussing fertility-related concerns with your patients?
-
4.
Approximately what percentage of your patients are candidates for fertility preservation? If unclear, probe: Why/why not?
-
5.
Can you tell me how often you answer the EPIC questions for fertility? Probe to find out if the questions are completed by the attending or by someone else on his/her team.
-
6.
At what point during your visit with a new patient do you discuss fertility-related concerns and complete the EPIC fertility questions? (Note: May already be clear from response to #1)
-
7.
In which situations do you use ‘N/A’ for informing a patient about the impact of treatment on fertility?
-
8.
When applicable, do you use the EPIC questionnaire as a direct referral to the patient navigator or do you make a separate referral? If unclear, probe: Why/why not?
-
9.
Do you make direct referrals to a reproductive specialist? If unclear, probe: Why/why not?
-
10.
Can you tell me what you think are the barriers to discussing fertility-related concerns with your patients? If unclear, probe typical barriers such as: patient’s cancer stage, timing of the start of treatment, parity, insurance, or financial issues
-
11.
Is there anything else you think is important for me to know about your practices concerning managing patient’s fertility-related concerns that I did not ask you?
Thank you for your time.
Young Adult Interview Guide
Thank you for taking the time to speak with me today about the impact of cancer upon your fertility. The purpose of the study is to examine patient and provider perspectives about fertility preservation options, and we are interested in hearing about your experiences and exploring any challenges you have faced in making decisions about your fertility. Note: If participant is confused by or unfamiliar with the term “fertility preservation”, re-phrase as “maintaining the ability to have children.”
-
1.
Please tell me about your experience managing any fertility-related concerns before you began your treatment.
-
2.
Did you understand how treatment would affect your fertility? If unclear, probe: Why/why not?
-
3.
Can you tell me if you discussed fertility preservation options with your oncologist? If unclear, probe: Why/why not? Also probe to determine who patients may have discussed fertility preservation options with in lieu of their oncologist.
-
4.
What do you think is the most important piece of information that your oncologist [or provider identified in #3] told you regarding fertility preservation?
-
5.
Is there any information you wish your oncologist had told you about fertility preservation that he or she did not? Why?
-
6.
Did you meet with the fertility preservation patient navigator? If unclear, probe: Why/why not?
-
7.
Did you take any steps to preserve your fertility? If unclear, probe: Why/why not?
-
8.
Can you tell me about what influenced your decision regarding fertility preservation options?
-
9.
Please tell me how you felt about your decision after you made it back then? How do you feel about your decision now? If unclear, probe: Are you able to have children today?
-
10.
Please tell me what your experience has been like with fertility follow-up care. Note: May be N/A for some.
-
11.
Please tell me what resources you used, if any, from organizations that provide reproductive information and support for patients and their families. If not mentioned, probe: Have you heard about websites like fertilehope.org , myoncofertility.org , savemyfertility.org , fertilitypreservation.northwestern.edu, liveonkit.com , or The American Cancer Society and The National Cancer Institute?
-
12.
Please tell me about any specific barriers or things that got in the way of you getting fertility preservation care. If unclear, probe typical barriers such as: cancer stage, timing of the start of treatment, parity, insurance, or financial issues.
-
13.
Is there anything else you think is important for me to know about your experiences managing your fertility-related concerns that I did not ask you?
Thank you for your time.
Rights and permissions
About this article
Cite this article
Salsman, J.M., Yanez, B., Snyder, M.A. et al. Attitudes and practices about fertility preservation discussions among young adults with cancer treated at a comprehensive cancer center: patient and oncologist perspectives. Support Care Cancer 29, 5945–5955 (2021). https://doi.org/10.1007/s00520-021-06158-0
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00520-021-06158-0